So today marks the change in short selling rules. Yet we saw no change in the share price. In fact we saw a further decline. So what does the price movement tell us?
1. Shorts are extremely confident in continued downward pressure.
2. There are no new retail investors buying to force short sellers to cover.
3. The reasons for shorts staying in and retail staying out are probably the same. Lack of faith in management, concerns about bankruptcy, concerns over failed studies, and Nader.
4. Class actions moving forward. History of being high vulnerability to lawsuits.
5. Competition with against more competent biotechs that are now further along.
Basically in order for CYDY to see new investors and better prospects it needs better management, better designed studies, and possibly a reverse split to uplist.
AI
Market Data 
Markets 
